| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/17/2005 | US20050037462 Expression vector comprising nucleotide sequences coding g protein for use in generating immunoglobulins for use in prevention, treatment and diagnosis of cell proliferative disorders |
| 02/17/2005 | US20050037092 Vascularization therapy by highly concentrated carbonated warm water bath |
| 02/17/2005 | US20050037029 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 02/17/2005 | US20050037028 Topical antiallergenic cream containing Asian longhorn beetle wastes; animal extracts |
| 02/17/2005 | US20050037017 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/17/2005 | US20050037009 Methods and reagents for protease inhibition |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050037002 Synergistic mixture of a blocking agent of an inhibitory receptor or stimulant of an activating receptor of natural killer cells and an antibody that can be bound by the CD16 antigen; efficiency is enhanced through the increase of the antibody-dependent cellular cytoxicity mechanism |
| 02/17/2005 | US20050036996 Absorbable composition containing propionic bacteria capable of releasing nitric oxide in the human or animal alimentary canal |
| 02/17/2005 | US20050036994 Compounds and methods for downregulating the effects of TGF-beta |
| 02/17/2005 | US20050036991 For preventing and/or treating transplant/xenotransplant rejection; interleukin-1B converting enzyme inhibitors |
| 02/17/2005 | US20050036989 Subgroup B adenoviral vectors for treating disease |
| 02/17/2005 | US20050036985 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/17/2005 | DE10331974A1 Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren A process for the preparation and use antimicrobial proteins inducing factors |
| 02/17/2005 | CA2575591A1 A pharmaceutical composition for treatment of cancers |
| 02/17/2005 | CA2535098A1 Method for inhibiting bacterial colonisation |
| 02/17/2005 | CA2534591A1 Method for purifying mesenchymal stem cells |
| 02/17/2005 | CA2532444A1 Compositions containing macrophages and uses thereof |
| 02/17/2005 | CA2519294A1 Newcastle disease virus administration |
| 02/16/2005 | EP1506999A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 02/16/2005 | EP1506997A1 Method of generating neural stem cells |
| 02/16/2005 | EP1506785A1 Composition for treating or preventing hyperuricemia |
| 02/16/2005 | EP1506781A1 Vaginal care composition |
| 02/16/2005 | EP1506317A2 Marker molecules associated with lung tumors |
| 02/16/2005 | EP1506301A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 02/16/2005 | EP1506285A2 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 02/16/2005 | EP1506021A2 Novel use of adenoviruses and nucleic acids coding therefor |
| 02/16/2005 | EP1506013A1 Chimeric allograft tolerance induction, monitoring and maintenance |
| 02/16/2005 | EP1506009A2 Glucan-based vaccines |
| 02/16/2005 | EP1505994A1 Novel use of the extract of processed ginseng and saponin isolated therefrom |
| 02/16/2005 | EP1505993A1 Sensitization of neoplastic cells to radiation therapy with oncolytic viruses |
| 02/16/2005 | EP1505992A1 Method for reducing pain using oncolytic viruses |
| 02/16/2005 | EP1505991A1 A drugs association against influenza virus |
| 02/16/2005 | EP1505989A2 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration |
| 02/16/2005 | EP1505973A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/16/2005 | EP1505943A1 Allograft bone composition having a gelatin binder |
| 02/16/2005 | EP1505873A2 Universal chimera bank |
| 02/16/2005 | EP1102531B1 Method and device for rearing fly larvae for therapeutic application |
| 02/16/2005 | EP0858502B1 Normal neural epithelial precursor cells |
| 02/16/2005 | EP0634896B1 Evaluation of patients with progressive immunosuppression |
| 02/16/2005 | CN1582337A 丙型肝炎病毒疫苗 Hepatitis C Virus Vaccine |
| 02/16/2005 | CN1582331A Endothelial cells derived from primate embryonic stem cells |
| 02/16/2005 | CN1582178A Hematopoietic stem cell gene therapy |
| 02/16/2005 | CN1582172A Treating canker sores with patches to speed healing and relieve pain |
| 02/16/2005 | CN1582167A Cytokine-inducing material and cytokine-inducing tool |
| 02/16/2005 | CN1582165A Antibodies to CD40 |
| 02/16/2005 | CN1580266A Method for extablishing polymorphism adenoid tumour mouse model |
| 02/16/2005 | CN1580262A Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 02/16/2005 | CN1580072A SARS coronary virus nail protein high-immune-protosegment, coding sequence and its use |
| 02/16/2005 | CN1580068A Method for preparing injection ribonucleic acid of human placenta |
| 02/16/2005 | CN1579541A Compound bone peptide for injection and its preparation process |
| 02/16/2005 | CN1579536A Method for preparing anti-hepatitis-B humanbody placenta transfer factor powder injecta |
| 02/16/2005 | CN1579424A Prevention of disease induced by taking high phenylalanine and treatment there for |
| 02/16/2005 | CN1579423A Compound comprised royal jelly and nutrient composition comprising said compound |
| 02/16/2005 | CN1579422A Fetus toxic liquid and its use for preparing baby's skin external products |
| 02/16/2005 | CN1579421A Freeze-dried powder of pig's lung surface matter, its preparation method and use |
| 02/16/2005 | CN1579420A Veal-blood protein-removed extract infusion and its preparation process |
| 02/16/2005 | CN1579250A Health drink of donkey-hide gelatin and its preparation method |
| 02/16/2005 | CN1579231A Chinese-date lozenge |
| 02/16/2005 | CN1579227A Bird-animal bone super-fine powder and its preparation process |
| 02/16/2005 | CN1189560C Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 02/16/2005 | CN1189208C Chinese medicine composition for curing child common cold fever |
| 02/16/2005 | CN1189204C Medicine compositions for treating biliary calculus, and its prepn. method |
| 02/16/2005 | CN1189197C Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promting blood circulation and promoting tissue regeneration |
| 02/16/2005 | CN1189194C Medicine for curing cervucal spondylopathy and verebrae lumbales diseases |
| 02/16/2005 | CN1189193C Ointment for treating burn |
| 02/16/2005 | CN1189192C Chiense medicine for treating bone fracture |
| 02/16/2005 | CN1189191C Nephrosis treating medicine and its prenp |
| 02/16/2005 | CN1189190C Ointment for treating gastritis gastric and duodenal ulcer and ulcer colonitis |
| 02/16/2005 | CN1189189C Medicine for eliminating thrombus and treating apoplexy |
| 02/16/2005 | CN1189188C Leukoderma curing plaster |
| 02/16/2005 | CN1189186C Antiphlogistic and analgesic ointment for treating rheumatism and trauma |
| 02/16/2005 | CN1189185C Woodfrog egg oil capsule and its production process |
| 02/16/2005 | CN1189184C External use medicine for treating haemorrhoid and preparation method thereof |
| 02/16/2005 | CN1189183C Yunnan Heiyao and its application in treating viral, bacterial and fungal diseases |
| 02/16/2005 | CN1189162C Formulation and prodution process of bee glue capsule |
| 02/15/2005 | US6855860 Nonocclusive dressing comprising natural polymer fibers and a synthetic polymer foam layer having a pore-containing surface physically interlocked with the fibers; separation; nonadhesive; easy to manufacture; nontoxic; permeability |
| 02/15/2005 | US6855803 Protein having hemolytic activity and gene encoding the protein |
| 02/15/2005 | US6855770 Drug delivery compositions and medical devices containing block copolymer |
| 02/15/2005 | US6855694 Prophylaxis of nervous system disorders comprising administering ubiquitin and liver extracts |
| 02/15/2005 | US6855691 Methods for producing and using S-nitrosohemoglobins |
| 02/15/2005 | US6855687 Administering to the site in need of cartilage repair a polypeptide having the sequence Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Cys-Glu-Gl y-Asp-Ser-Pro-Phe-Val |
| 02/15/2005 | US6855686 Also administering to the subject an effective amount of an mda-7 protein. |
| 02/15/2005 | US6855683 Hypersensitive response elicitor from Erwinia amylovora, its use, and encoding gene |
| 02/15/2005 | US6855534 Enhanced system for construction of adenovirus vectors |
| 02/15/2005 | US6855489 Systems and methods for removing viral agents from blood |
| 02/15/2005 | US6855350 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 02/15/2005 | US6855346 Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same |
| 02/15/2005 | US6855345 Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions |
| 02/15/2005 | US6855338 Anti-tumor therapies comprising a combination of a cartilage extract and an anti-neoplastic agent providing high efficacy and low toxic side effects |
| 02/15/2005 | US6855337 Bear derived isolate and method |
| 02/15/2005 | US6855325 Preventing and limiting release of chemical mediators responsible for initiating cutaneous inflammation; cosmetics |
| 02/15/2005 | US6855317 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/15/2005 | US6855102 Method for separating cells, especially platelets, and bag assembly therefor |
| 02/15/2005 | CA2119562C Method and compositions for the treatment of cerebral palsy |
| 02/10/2005 | WO2005012536A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof |
| 02/10/2005 | WO2005012512A1 Scaffold-free self-organized 3d synthetic tissue |
| 02/10/2005 | WO2005012510A1 Method for the isolation and expansion of cardiac stem cells from biopsy |
| 02/10/2005 | WO2005012509A2 Method for immunotherapy of tumors |
| 02/10/2005 | WO2005012508A1 Skin regeneration system |